Home » Medtronic Initiates Landmark Study of Neurostimulation Therapy for Failed Back Surgery Syndrome

Medtronic Initiates Landmark Study of Neurostimulation Therapy for Failed Back Surgery Syndrome

January 28, 2013

Medtronic announced the start of PROMISE, a Prospective, Randomized Study of Multicolumn Implantable Lead Stimulation for Predominant Low Back Pain.
Yahoo! Finance

05Aug
Pharmaceutical Quality Risk Management: Navigating the Intersection Between Regulatory Requirements & Risk Management
10Aug
Is Biosimilars Regulation Taking a Major Turn?: The Latest Must-Know Developments, Including BsUFA III
12Aug
On-Site Inspections: They’re Back — But When, Where and How
16Aug
Using AI for CAPA and Root Cause Investigation
28Sep
4th Annual WCG MCC Clinical Trial Risk & Performance Management Collaborative vSummit
12Oct
Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

Medtronic Initiates Landmark Study of Neurostimulation Therapy for Failed Back Surgery Syndrome

Upcoming Events

Pharmaceutical Quality Risk Management: Navigating the Intersection Between Regulatory Requirements & Risk Management

Is Biosimilars Regulation Taking a Major Turn?: The Latest Must-Know Developments, Including BsUFA III

On-Site Inspections: They’re Back — But When, Where and How

Using AI for CAPA and Root Cause Investigation

4th Annual WCG MCC Clinical Trial Risk & Performance Management Collaborative vSummit

Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

Featured Products

Biological Risk Evaluation and Management for Medical Devices

GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

BioNTech to Develop the First mRNA-Based Vaccine for Malaria Prevention

Gnomon Informatics Gets CE Mark for Medical Device Software

Third Pfizer Vaccine Dose Ratchets Up Protection Against Delta Variant

Asensus Surgical Gets FDA 510(k) Clearance for Articulating Instruments

The Revised ICH E8: A Guide to New Clinical Trial Requirements